Assembly and weak interactions in the crystal structure of 2-amino-4-(3-bromophenyl)-1,3,5-triazinobenzimidazolium chloride studied by X-ray diffraction, vibrational spectroscopy, Hirshfeld surface analysis and DFT calculations
-
Add time:07/11/2019 Source:sciencedirect.com
Experimental and theoretical investigations on the molecular structure, electronic and vibrational properties of the title compound are presented in this study. The asymmetric unit of the 2-amino-4-(3-bromophenyl)-1,3,5-triazinobenzimidazolium chloride consists of a discrete protonated cations assembled with the chloride anion via NH⋯Cl, CH⋯Cl and NH⋯N hydrogen bonds. Moreover, the protonated aromatic system shows a π-π interaction adding an extra stability to the 2D architecture. Hirshfeld surface analysis employing 3D molecular surface contours and 2D fingerprint plots have been used to analyze intermolecular interactions present in the solid state. The ground state geometry of the title compound was optimized using density functional theory (DFT) at the 6311 + G(2d,2p) level of theory. Molecular parameters calculated using CPCM model of solvation has resulted in better agreement with measured spectra.
We also recommend Trading Suppliers and Manufacturers of 4-(2-Amino-4-bromophenyl)-2-piperazinone (cas 1016845-08-1). Pls Click Website Link as below: cas 1016845-08-1 suppliers
Prev:Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects
Next:Experimental and theoretical characterization of organic salt: 2-((4-bromophenyl)amino) pyrido[1,2-a] quinoxalin-11-ium bromide monohydrate synthesized via oxidative cyclization) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Regioselective cyclometallation of N-methyl-N-(naphthalen-2-ylmethyl)-2-(pyridin-2-yl)ethanamine with palladium(II) acetate and catalytic reduction of various functional groups07/16/2019
- Synthesis and structure–activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists07/15/2019
- Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)07/14/2019
- Novel 2-phenyl-6-phenylethynyl-4-(trifluoromethyl)quinolines: Synthesis by Sonogashira cross-coupling reaction and their evaluation as liquid crystals07/13/2019
- Experimental and theoretical characterization of organic salt: 2-((4-bromophenyl)amino) pyrido[1,2-a] quinoxalin-11-ium bromide monohydrate synthesized via oxidative cyclization07/12/2019


